Latest News & Updates
Breaking News
4 hours ago
Simantini Singh Deo
Other trending news you may like to read
Lungpacer Medical Strengthens Leadership Team With Appointment Of Steven Pfanstiel As The New Chief Financial Officer
Lungpacer Medical appoints Steven Pfanstiel as CFO, bringing nearly 25 years of medical device and biotech experience to advance AeroPace System commercialization and company growth.
Simantini Singh Deo
Patent Dispute Ends As UroGen And Teva Reach Agreement On JELMYTO Generic Launch: Here's What Changed!
UroGen Pharma settles JELMYTO patent dispute with Teva, granting a non-exclusive generic license effective September 15, 2030, pending FDA approval and preserving core patent rights.
Simantini Singh Deo
Johnson & Johnson Achieves Phase 2 Primary Endpoint for Nipocalimab in Moderate-to-Severe SLE
J&J's nipocalimab met Phase 2 primary endpoint in SLE; Phase 3 underway, raising CMC and BLA readiness questions for FcRn blocker manufacturing.
Simantini Singh Deo
Novo Nordisk Launches Wegovy Pill in UAE as First Market Outside United States
Novo Nordisk launches oral semaglutide in the UAE, the first market outside the US, with further launches confirmed for H2 2026.
Simantini Singh Deo
